134 completed, 17 unknown, 15 recruiting, 14 terminated. 61 Phase 2, 54 Phase 3, 41 Phase 1, 32 Not applicable, 18 Phase 4.
Follow Placebo tablet: new trials by email Literature Review of Placebo tablet trials Research Report on Placebo tablet
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lemborexant Use for Cognition Improvement in Postoperative Delirium in Elderly Patients: A Randomized Controlled Trial Lemborexant Pill, Placebo tablet - Postoperative Delirium | Phase 2 | Not yet recruiting | Beijing Tiantan Hospital | 992 | 2026-09-01 | 2026-07-14 |
| QT Interval Effects Study of Oral FXS5626 Tablets FXS5626 tablet, Placebo tablet - Evaluation of QTc Interval | Phase 1 | Recruiting | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 28 | 2026-08-13 | 2026-10-14 |
| Protective Role of Alpha-Lipoic Acid in Chemotherapy-Induced Mucositis alpha lipoic acid 600 mg twice daily, Placebo Tablet - Colorectal Cancer | Phase 2 / Phase 3 | Recruiting | Ain Shams University | 50 | 2026-07-27 | 2026-07-30 |
| A Study to Investigate the Biomarkers of Hemay005 in Adult Participants With Moderate to Severe COPD Hemay005 tablets, Roflumilast Oral Tablet, Placebo tablet - COPD (Chronic Obstructive Pulmonary Disease) | Phase 2 | Not yet recruiting | Ganzhou Hemay Pharmaceutical Co., Ltd | 120 | 2026-01-01 | 2026-01-02 |
| A Study to Evaluate Single and Multiple Doses of TLC-1180 in Healthy Subjects TLC-1180 Oral Solution, TLC-1180 Tablet, Placebo Oral Solution - Healthy Participants | Phase 1 | Recruiting | OrsoBio, Inc | 332 | 2025-10-20 | 2026-08-21 |
| Computational Assessment of GABA Receptor Modulation in PTSD Lorazepam 1 mg tablet, Placebo tablet - Stress Disorders, Post-Traumatic | Phase 4 | Recruiting | VA Office of Research and Development | 150 | 2025-07-01 | 2026-06-16 |
| CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation Dapagliflozin tablet, Placebo Tablet - Fontan Circulation, Single Ventricle Heart Disease | Phase 2 | Recruiting | Mayo Clinic | 27 | 2025-05-16 | 2026-05-06 |
| Aspirin for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease Aspirin 81 mg Enteric Coated Tab - 1 tablet, Placebo - Metabolic Dysfunction Associated Steatotic Liver Disease | Phase 2 | Recruiting | Taichung Veterans General Hospital | 120 | 2025-05-05 | 2025-05-11 |
| Effect of Empagliflozin on Left Atrial Function in Adults at Risk for Heart Failure empagliflozin, Placebo tablet - Hypertension, Cardiovascular Diseases | Early Phase 1 | Recruiting | University of Minnesota | 80 | 2024-12-12 | 2026-10-20 |
| Clinical Trial of AGB101 for Mild Cognitive Impairment AGB101, Placebo - Mild Cognitive Impairment, Prodromal Alzheimer's Disease | Phase 2 | Withdrawn | AgeneBio | 2024-12-03 | 2025-05-25 | |
| A Study to Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy Participants CKD-508 Tablet, Placebo Tablet - Healthy Subjects | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 44 | 2024-11-14 | 2026-02-27 |
| Clinical Study to Evaluate the Efficacy and Safety of GS1-144 Tablets in the Treatment of Moderate to Severe Vasomotor Symptoms in Chinese Postmenopausal Women. Placebo, GS1-144 - Vasomotor Syndrome | Phase 2 | Completed | Changchun GeneScience Pharmaceutical Co., Ltd. | 129 | 2024-10-14 | 2026-04-29 |
| A Study of Pitolisant in Patients With Prader-Willi Syndrome Pitolisant tablet, Placebo tablet - Prader-Willi Syndrome | Phase 3 | Recruiting | Harmony Biosciences Management, Inc. | 134 | 2024-05-28 | 2026-08-25 |
| L-arginine for Knee Osteoarthritis Patients L-arginine tablet, Placebo tablet - Osteoarthritis, Knee | Not applicable | Recruiting | Xiangya Hospital of Central South University | 340 | 2024-03-20 | 2025-06-02 |
| A Phase I Study of XH-S004 in Healthy Volunteers XH-S004 tablet, Placebo tablet - Healthy Adults | Phase 1 | Completed | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 106 | 2024-02-17 | 2026-09-25 |
| Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis Frexalimab, Teriflunomide, Placebo infusion - Multiple Sclerosis | Phase 3 | Active not recruiting | Sanofi | 1655 | 2023-12-13 | 2026-07-20 |
| Dopaminergic Therapy for Anhedonia - 2 Carbidopa Levodopa, Placebo - Anhedonia, Depression | Phase 4 | Recruiting | Emory University | 70 | 2023-11-21 | 2026-01-28 |
| Ivermectin Safety in Small Children Oral ivermectin, Permethrin Cream, Placebo tablet - Scabies | Phase 2 | Completed | University of Oxford | 240 | 2023-11-18 | 2025-12-18 |
| NanaBis™ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers NanaBis™, Oxycodone CR, Placebo Spray - Cancer Related Pain | Phase 3 | Unknown | Medlab Clinical | 360 | 2023-11-01 | 2022-04-12 |
| XG005 for Pain Control in Subjects Undergoing Bunionectomy XG005 tablet, Placebo tablet - Acute Pain | Phase 2 / Phase 3 | Completed | Xgene Pharmaceutical Group | 450 | 2023-08-29 | 2025-11-17 |
Showing 20 of 191. Sign in to see all of them.
Diabetes Mellitus (10) · Diabetes Mellitus, Type 2 (10) · Pain (8) · Depression (6) · Inflammation (6) · Rhinitis, Allergic (6) · Insulin Resistance (5) · Asthma (4) · Cognitive Dysfunction (4) · Heart Failure (4) · Hypersensitivity (4) · Obesity (4) · Osteoarthritis, Knee (4) · Pain, Postoperative (4) · Arthritis (3)
Stallergenes Greer (7) · AstraZeneca (5) · Daiichi Sankyo (5) · Boehringer Ingelheim (4) · Columbia University (4) · Bayer (3) · Damanhour University (3) · Eli Lilly and Company (3) · Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division (3) · Organon and Co (3) · The University of Texas Health Science Center at San Antonio (3) · Ain Shams University (2) · Chong Kun Dang Pharmaceutical (2) · Diskapi Yildirim Beyazit Education and Research Hospital (2) · Emory University (2)
United States (84) · China (23) · Canada (16) · Germany (16) · France (14) · United Kingdom (13) · Denmark (12) · Australia (11) · Belgium (11) · Poland (11) · Italy (9) · Mexico (9) · Spain (9) · Hungary (8) · Netherlands (8)
Bret R Rutherford, MD (2) · Jennifer Felger, PhD (2) · Rehab H Werida, Ass Prof. (2) · Reyhan Polat, MD (2) · Ain Shams (1) · Albert Lie, Dr (1)
PMID 31284771, PMID 39035788, PMID 39077939, PMID 10588598, PMID 17935764, PMID 18765484, PMID 18824641, PMID 19046761, PMID 19486429, PMID 19647862, PMID 20166794, PMID 20559006, PMID 20580422, PMID 20592433, PMID 20599398, PMID 20720259, PMID 20805005, PMID 21231862, PMID 21434995, PMID 21939549, PMID 22170358, PMID 22236356, PMID 22297243, PMID 22626819, PMID 22750403, PMID 22824930, PMID 22935052, PMID 22945607, PMID 22994348, PMID 23039868, PMID 23097272, PMID 23181790, PMID 23294774, PMID 23346990, PMID 23522121, PMID 23579178, PMID 23676577, PMID 23748506, PMID 23748507, PMID 23800482, PMID 24261946, PMID 24296715, PMID 24366914, PMID 24372992, PMID 24388010, PMID 24621999, PMID 24762094, PMID 24991933, PMID 25468655, PMID 25733652
2019 (3), 2004 (1), 2008 (1), 2009 (1), 2023 (1), K23HD052550 (1), K24MH122514 (1), R01AA020504 (1), R01AG049762 (1), R01CA136918 (1), R01DK096982 (1), R01HL077389 (1), R01MH123660 (1), R33MH121625 (1), R61MH121625 (1)